ARCHIVES

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

This article is from The Cancer Letter archive.

Vol. 11 No. 31 | August 2, 1985

Download PDF Visit The Full Archive

Related Articles

Medline Plus Provides Info To Patients About Prescriptions

May 28, 2004

An Impromptu Group Proposes Standards For Publication Of Genomics Research

October 1, 2010

PROPOC Study Analyses Six Cancer DRGs

January 17, 1986

Spectral Mammography “Like Color vs. Black & White TV”

August 31, 2012

In Brief: UCSD Recruits Mitchell From USC; Wade Wins Policy Fellowship; ASCO Honors Burchenal

July 15, 1994

NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement

June 26, 1987